Anti-Müllerian hormone (AMH) levels in ng/ml decline steadily with age, and a normal AMH by age chart in ng/ml runs from roughly 2.5 to 6.5 ng/ml in the early twenties down to below 0.5 ng/ml after age 40. The single most important reference point is 1.0 ng/ml, the conventional threshold for diminished ovarian reserve. A value above 1.0 ng/ml is generally considered normal at any reproductive age. Values between 0.5 and 1.0 ng/ml suggest a reduced egg pool. Anything under 0.5 ng/ml is low. A value above the age-appropriate upper bound, usually over 6 to 7 ng/ml, points toward polycystic ovary syndrome rather than exceptional fertility.
What AMH Actually Measures and Why It Falls
AMH is a glycoprotein hormone secreted by the granulosa cells of small antral follicles, the fluid-filled cysts about 2 to 9 millimeters across that sit in the ovary before one is selected to ovulate. Each of these follicles releases a small amount of AMH. The sum of those signals is what a blood test reads. In practical terms, AMH is a headcount of a specific stage of follicles, not a measure of egg quality and not a direct measure of how many eggs remain.
The mechanism behind the age decline is a two-part story. First, the raw number of resting follicles drops from about 1 to 2 million at birth to roughly 25,000 at age 37 and under 1,000 at menopause. Fewer follicles in the growing pool means less AMH output. Second, and less obvious, AMH production per follicle may fall as the cohort ages, so the hormone curve can steepen faster than the follicle count alone would predict. This is why AMH is best read as a trend rather than a single snapshot.
In plain terms: AMH tells you how loud the ovarian "choir" is, and the choir shrinks with age. It does not tell you how well any individual singer performs.
One laboratory detail matters for anyone comparing numbers. AMH assays are not standardized. The older Gen II ELISA and the newer automated assays (Roche Elecsys, Beckman Access) can disagree by 20 to 30 percent on the same sample. Per the 2023 international consensus on AMH testing, clinicians should use one assay platform and one laboratory when tracking change over time, and should not compare values across platforms.
The Age-by-Age AMH Chart in ng/ml
The table below reflects pooled reference ranges from large reproductive-age cohorts and clinical laboratory data. These are population medians and typical ranges, not individual guarantees. Two women of the same age can sit a full standard deviation apart and both be normal.
| Age band | Typical median (ng/ml) | Common normal range (ng/ml) | Interpretation |
|---|---|---|---|
| 20-24 | 3.5-4.5 | 1.5-6.5 | Peak ovarian reserve |
| 25-29 | 3.0-4.0 | 1.2-6.0 | Still high, first measurable dip |
| 30-34 | 2.5-3.5 | 1.0-5.5 | Gradual decline begins |
| 35-37 | 1.8-2.8 | 0.7-4.5 | Faster slope; 1.0 threshold looms |
| 38-40 | 1.2-2.0 | 0.4-3.5 | Diminished reserve common |
| 41-42 | 0.7-1.3 | 0.2-2.5 | Most values below 1.5 |
| 43-45 | 0.3-0.8 | 0.05-1.5 | Low range dominates |
The steepest part of the curve sits between ages 35 and 40, when median AMH roughly halves. That is a faster drop than most people expect, and it is the reason fertility guidance shifts at 35 rather than at 40.
A quantified comparison worth holding onto: across the full span from age 25 to age 43, median AMH falls by about 85 to 90 percent, from roughly 3.5 ng/ml to roughly 0.5 ng/ml. Over the same 18-year window, the raw follicle count falls from around 150,000 to around 8,000, a drop of about 95 percent. The hormone curve trails the follicle curve slightly, which is why AMH can look "fine" in the late thirties even as the reserve is thinning quickly.
How Fast AMH Falls: A Timeline
The rate of decline varies enormously between individuals, but the population pattern is consistent enough to be useful. This timeline tracks the expected trajectory for a woman starting at an average AMH for her age.
| Age point | Expected median AMH (ng/ml) | Approximate decline from prior row | What changes clinically |
|---|---|---|---|
| Age 25 | 3.5 | Baseline | No action needed |
| Age 30 | 3.0 | About 15 percent over 5 years | Fertility counseling begins if planning delay |
| Age 35 | 2.2 | About 25 percent over 5 years | Egg-freezing discussion window narrows |
| Age 38 | 1.5 | About 30 percent over 3 years | 1.0 ng/ml threshold within reach |
| Age 40 | 1.1 | About 25 percent over 2 years | Diminished reserve likely |
| Age 42 | 0.7 | About 35 percent over 2 years | Most values below 1.0 |
| Age 44 | 0.4 | About 40 percent over 2 years | Low reserve; menopause within years |
Two things stand out. The annual decline accelerates from about 3 percent per year in the mid-twenties to about 10 to 15 percent per year in the early forties. And the absolute drop per year is small until it is not: between ages 30 and 35, median AMH falls about 0.16 ng/ml per year, while between 40 and 44 it falls about 0.18 ng/ml per year from a much smaller base, so the relative loss is far steeper.
The 1.0 ng/ml Threshold and Other Cutoffs
Three AMH thresholds dominate clinical use, and they are often confused with one another. Here is how they reconcile:
- 1.0 ng/ml marks diminished ovarian reserve (DOR). Below this, response to ovarian stimulation is likely to be poor, and the time to pregnancy lengthens.
- 0.5 ng/ml marks a low response to IVF stimulation. Per the 2011 Bologna criteria, an antral follicle count under 5 to 7 or an AMH under 0.5 to 1.1 ng/ml defines a "poor ovarian responder."
- 0.1 ng/ml marks the practical floor. Below this, the chance of retrieving eggs for IVF approaches zero, though natural conception is still occasionally reported.
One sentence ties them together: 1.0 ng/ml is the warning line, 0.5 ng/ml is the low-response line, and 0.1 ng/ml is the near-empty line, and each is a population statistic rather than a personal verdict.
On the high side, a cutoff of about 6 to 7 ng/ml flags possible polycystic ovary syndrome, where many small follicles produce excess AMH. A value of 10 ng/ml or more warrants evaluation for PCOS and, rarely, for an AMH-secreting granulosa cell tumor.
What AMH Does Not Tell You
The most common misconception is that a low AMH means infertility. It does not. AMH predicts how many eggs a stimulation cycle will retrieve far better than it predicts whether a woman can conceive naturally. A 2017 study in JAMA of women aged 30 to 44 found that low AMH was not associated with reduced natural fertility after adjusting for age. Women with AMH under 0.7 ng/ml still conceived at rates comparable to women with normal AMH in that cohort.
The second misconception is that a high AMH means high fertility. A value of 7 ng/ml at age 32 usually signals PCOS, not a superior reserve. PCOS ovaries carry many small follicles that never mature normally, so a high AMH can coexist with irregular ovulation and lower per-cycle fertility.
A third point, often missed: AMH does not move with the menstrual cycle or with short-term lifestyle changes. It is stable across the cycle and fluctuates mainly with long-term factors such as smoking, which lowers AMH by roughly 10 to 20 percent, and obesity, which can raise it slightly. Vitamin D status has a modest effect that does not change clinical interpretation.
Reading Your Own Number
The single most useful habit is to read AMH against age, not against the lab's generic reference range. Many labs print "normal: 1.0 to 6.0 ng/ml" for all ages, which is misleading for a 42-year-old and for a 24-year-old alike. Always compare your value to the age band in the chart above.
A second habit is to repeat the test with the same assay before drawing conclusions. A single value of 0.9 ng/ml at age 36 is a data point; two values six months apart on the same platform showing 0.9 then 0.6 tells a real story.
If AMH is below 1.0 ng/ml and pregnancy is a goal, the practical actions that change outcomes are these:
- Ask for an antral follicle count by transvaginal ultrasound on cycle day 2 to 4 to confirm the AMH signal.
- Request a full reserve panel: day-3 FSH, estradiol, and inhibin B alongside AMH.
- Discuss time-to-pregnancy honestly with a reproductive endocrinologist rather than waiting another year.
- If considering egg freezing, treat the decision as time-sensitive; success rates drop sharply after age 38.
- Stop smoking and address any thyroid or vitamin D deficiency, which affect ovarian function broadly.
Limitations of Every AMH Chart
Every age chart in ng/ml carries uncertainty that the headline numbers hide. Assay differences alone can shift a value by 20 to 30 percent, meaning a "low" 0.9 ng/ml on one platform could read 1.2 ng/ml on another. Ethnic and body-mass variation also matter: AMH tends to run higher in women with obesity and lower in smokers, independent of true reserve.
The charts are cross-sectional, built from population medians at each age. They do not track individuals, and individual trajectories can be twice as steep or half as steep as the median. A 38-year-old with AMH of 2.0 ng/ml is well above the median and may still have a reserve that falls fast next year. A 30-year-old with 1.1 ng/ml may hold steady for a decade.
Finally, AMH cannot tell you egg quality, which declines with age on a separate clock driven by chromosomal error rates in the oocyte. Two women with identical AMH at age 40 can have very different chances of a healthy pregnancy. Treat the chart as a map of the terrain, not a forecast of the weather.